Researchers Identify Promising Target for CAR T-cell Therapy in Myeloma — Myeloma Research News

Designing CAR T-cells to specifically target GPRC5D — a protein appreciably present on the surface of myeloma cells — may be a safe and effective therapy against multiple myeloma, a preclinical study shows. The study, “GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells,” was published in the journal…

Researchers Identify Promising Target for CAR T-cell Therapy in Myeloma — Myeloma Research News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.